GT
CVAC

Greenleaf Trust’s CureVac CVAC Stock Holding History

Greenleaf Trust’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,036
Closed -$30.6K – 807
2025
Q1 		$30.6K Buy
+11,036
New +$38.4K ﹤0.01% 796
2024
Q4 		– Sell
-10,031
Closed -$29.5K – 817
2024
Q3 		$29.5K Sell
10,031
-554
-5% -$1.82K ﹤0.01% 831
2024
Q2 		$36K Buy
+10,585
New +$34.6K ﹤0.01% 791

Other funds holding CVAC

AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Greenleaf Trust's CVAC Position: Q2 2025 in Review

Greenleaf Trust sold out of CureVac (CVAC) in Q2 2025, closing a stake of 11,036 shares — an estimated $30.6K sold.

Greenleaf Trust first reported a position in CVAC in Q2 2024 and held it in 3 quarters. The position peaked at $36K in Q2 2024. 91 funds tracked by Wall St. Rank hold CVAC as of Q2 2025.

  • Greenleaf Trust reported no remaining CureVac position as of Q2 2025 after selling out during the quarter.
  • Greenleaf Trust sold 11,036 CureVac shares in Q2 2025, an estimated $30.6K.
  • Greenleaf Trust first reported a position in CureVac in Q2 2024 and held it in 3 quarters.
  • Greenleaf Trust's CureVac position peaked at $36K in Q2 2024.
  • 91 funds tracked by Wall St. Rank held CureVac as of Q2 2025.

Based on Greenleaf Trust's 13F filing for Q2 2025, filed 17 Jul 2025.